Author + information
- Received April 30, 2019
- Revision received August 1, 2019
- Accepted August 7, 2019
- Published online June 1, 2020.
- Michael Chetrit, MDa,b,∗,
- Bo Xu, MDa,b,∗,
- Deborah H. Kwona,b,
- Jay Ramchand, MDa,b,
- Rene E. Rodriguez, MDc,
- Carmela D. Tan, MDc,
- Christine L. Jellis, MDa,b,
- Douglas R. Johnston, MDa,d,
- Rahul D. Renapurkar, MDa,e,
- Paul C. Cremer, MDa,b and
- Allan L. Klein, MDa,b,∗ (, )@AllanLKleinMD1
- aCenter for the Diagnosis and Treatment of Pericardial Diseases, Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio
- bDepartment of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
- cDepartmemt of Cardiovascular Pathology, Cleveland Clinic, Cleveland, Ohio
- dDepartment of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio
- eImaging Institute, Cleveland Clinic, Cleveland, Ohio
- ↵∗Address for correspondence:
Dr. Allan L Klein, Center for the Diagnosis and Treatment of Pericardial Diseases, Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, Desk J1-5, Cleveland, Ohio 44195.
• Cardiac imaging is important in diagnosing acute and chronic pericardial inflammation.
• Cardiac imaging has redefined the approach of pericardiologists to diagnosis.
• Image-guided therapies can improve overall outcomes and shorten durations of therapy.
Frequently, multimodality imaging is indispensable in the care of patients with pericardial disease. With cardiac magnetic resonance imaging, pericardial inflammation can be characterized as acute, subacute, or chronic. This spectrum of inflammation is variably associated with reduced compliance of the pericardium, which may result in constrictive pathophysiology, typically well-defined with echocardiography. This interplay between inflammation and hemodynamics is often optimally characterized with multimodality imaging and has redefined the approach of pericardiologists to diagnose, prognosticate, and tailor individual therapies.
↵∗ Drs. Chetrit and Xu are joint first authors of this paper.
Drs. Cremer and Klein has a research grant from Kiniksa; and is part of the steering committee of Kiniksa and SOBI. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC: Cardiovascular Imaging author instructions page.
- Received April 30, 2019.
- Revision received August 1, 2019.
- Accepted August 7, 2019.
- 2020 American College of Cardiology Foundation
This article requires a subscription or purchase to view the full text. If you are a subscriber or member, click Login or the Subscribe link (top menu above) to access this article.